RESEARCH PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Although the Lithuanian government increases funding for the cervical cancer prevention program every year, the incidence and mortality rates of cervical cancer are among the highest in Europe. In order to improve the prevention policy regarding cervical cancer, it is necessary to investigate the implementation of the cervical cancer prevention policy in one of the regions in Lithuania.

Methods:
A quantitative survey method—a questionnaire—was applied in one of the regions of Lithuania. The study was conducted from April 1, 2022, until April 18, 2022. During the study, 213 residents of the investigating region were interviewed.

Results:
Respondents evaluated the cervical cancer prevention program in the investigated region positively, but not all women received invitations to participate in this program. The research revealed that the residents of the city of investigation have received this invitation more often than the women living in other districts.

Conclusions:
Women’s opinion about the effectiveness of the cervical cancer prevention program is positive. Still, there is an emphasis on the wish that this program could be used from an earlier age than 25 and continue longer than up to 59, and it is also noted that the prevention program could be carried out more often than is currently established.

ACKNOWLEDGEMENTS
The authors thank the informants who volunteered to give all the relevant information for the study.
CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for disclosure of Potential Conflicts of Interest and none was reported.
FUNDING
There was no source of funding for this research.
ETHICAL APPROVAL AND INFORMED CONSENT
Mykolas Romeris University Ethical approval was given (No. 20-11-2019).
DATA AVAILABILITY
The data supporting this research are available from the authors on reasonable request.
AUTHORS' CONTRIBUTIONS
GBŽ initiated research, wrote the research paper and manuscript, supervised data collection and analysis. AL participated in study design, conducted the field work and helped with the data analysis. All the authors have supervised data analysis and interpreted the data, read and approved the final manuscript paper.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
DISCLAIMER
A. Liepinaitienė reports that she is an Editorial Board Member of The European Journal of Midwifery. She had no involvement in the peer-review or acceptance of this article, and had no access to information regarding its peer-review. Full responsibility for the editorial process for this article was delegated to a handling editor of the journal.
 
REFERENCES (15)
1.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169-182. doi:10.1016/S0140-6736(18)32470-X
 
2.
Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020;112(2):229-232. doi:10.1016/j.jnma.2020.03.002
 
3.
Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720-728. doi:10.21147/j.issn.1000-9604.2020.06.05
 
4.
Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602-608. doi:10.1080/01443615.2019.1634030
 
5.
Miller AB. Cervix cancer. In: Kramer BS, Gohagan JK, Prorok PC, eds. Cancer screening. (pp. 195-217). CRC Press; 1999:195-217.
 
6.
Ferrall L, Lin KY, Roden RBS, Hung CF, Wu TC. Cervical Cancer Immunotherapy: Facts and Hopes. Clin Cancer Res. 2021;27(18):4953-4973. doi:10.1158/1078-0432.CCR-20-2833
 
7.
Hull R, Mbele M, Makhafola T, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20(3):2058-2074. doi:10.3892/ol.2020.11754
 
8.
Kojalo U, Tisler A, Parna K, et al. An overview of cervical cancer epidemiology and prevention in the Baltic States. BMC Public Health. 2023;23(1):660. doi:10.1186/s12889-023-15524-y
 
9.
Everatt R, Kuzmickienė I, Intaitė B, Anttila A. Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania. Eur J Cancer Prev. 2020;29(6):504-510. doi:10.1097/CEJ.0000000000000603
 
10.
Kuciauskaite G, Jariene K, Kvitkovskaja K. An audit of colposcopy cases for cervical cancer prevention in Lithuanian hospitals. Eur J Obstet Gynecol Reprod Biol. 2024;293:102. doi:10.1016/j.ejogrb.2023.08.286
 
11.
Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical Cancer Screening: Past, Present, and Future. Sex Med Rev. 2020;8(1):28-37. doi:10.1016/j.sxmr.2019.09.005
 
12.
Canfell K, Kim JJ, Brisson M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591-603. doi:10.1016/S0140-6736(20)30157-4
 
13.
Razali N, Mostafa SA, Mustapha A, Abd Wahab MH, Ibrahim NA. Risk factors of cervical cancer using classification in data mining. J Phys Conf Ser. 2020;1529(2):022102. doi:10.1088/1742-6596/1529/2/022102
 
14.
Elshami M, Thalji M, Abukmail H, et al. Knowledge of cervical cancer risk factors among Palestinian women: a national cross-sectional study. BMC Womens Health. 2021;21(1):385. doi:10.1186/s12905-021-01510-2
 
15.
Nagendiram A, Bougher H, Banks J, Hall L, Heal C. Australian women's self-perceived barriers to participation in cervical cancer screening: A systematic review. Health Promot J Austr. 2020;31(3):343-353. doi:10.1002/hpja.280
 
eISSN:2585-2906
Journals System - logo
Scroll to top